Viz.ai Expands into Lung Disease to Accelerate Diagnosis and Care for Patients
New software will incorporate natural language processing (NLP) for more effective patient screening and follow-up SAN FRANCISCO – October 21,...
Oct 21, 2024
All Resources
Explore our latest resources
Oct 20, 2024
Viz.ai Announces New Clinical Data Demonstrating Fewer Futile Transfers and Substantial Cost Savings...
Company’s artificial intelligence technology shows 14% increase in patient transfers treated with endovascular thrombectomy supporting its impact on improved care...
Sep 26, 2024
Sep 25, 2024
Sep 25, 2024
September 17, 2024
TIME Selects Viz.ai CEO Dr. Chris Mansi in TIME100 AI List of the...
SAN FRANCISCO – September 5, 2024 - Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, is pleased...
Sep 05, 2024